Skip to content.
Menu
Team
Team
Our philosophy
Companies
Build
Spotlight
We are hiring
Team
Team
Our philosophy
Companies
Build
Spotlight
We are hiring
Spotligh
t
Featured
Perspectives
Why we invested in OpenTrade
Read: Why we invested in OpenTrade
1 / 7
Read more
Perspectives
Why we invested in Infact
Read: Why we invested in Infact
2 / 7
Read more
Perspectives
Why we invested in trumpet
Read: Why we invested in trumpet
3 / 7
Read more
Perspectives
Why we invested in Instinct
Read: Why we invested in Instinct
4 / 7
Read more
Perspectives
Why we invested in Treefera
Read: Why we invested in Treefera
5 / 7
Read more
Perspectives
Why we invested in Oriole Networks
Read: Why we invested in Oriole Networks
6 / 7
Read more
Perspectives
Why we invested in Gridcog
Read: Why we invested in Gridcog
7 / 7
Read more
All
Deep dives
Events
Founder stories
News
Perspectives
Portfolio News
Web
All
AI / Data
Climate Tech
Deeptech
Digital Risk
Fintech
Healthtech
Life Sciences
University Spinouts
Search for:
Search
Perspectives
Deeptech Mash with Dave & Seb: Episode 3
Deeptech Mash: Episode 3
Read the article >
Perspectives
Deeptech Mash with Dave & Seb: Episode 2
Deeptech Mash: Episode 2
Read the article >
Perspectives
AlbionVC year in review
Read the article >
Perspectives
Deeptech Mash with Dave & Seb: Episode 1
Deeptech Mash: Episode 1
Read the article >
Perspectives
Why we invested in Oriole Networks
Read the article >
Perspectives
Our journey with Odin Vision
Our journey with Odin Vision
Read the article >
Perspectives
What do Founders worry about?
Reflections on CogX Founder Roundtable
Read the article >
Perspectives
A computing impasse – the investments we make now will define our future
Read the article >
Perspectives
Why we invested in Brytlyt?
Read the article >
Perspectives
What's happening in biotech?
On not downclimbing – the prospects for early stage biotech remain bright
Read the article >
Perspectives
Why we invested in Carbon Re?
Read the article >
Perspectives
Will the boom last?
A window to the past: is the investment boom in biotech going to last?
Read the article >
See more